Patents Assigned to VIDAC
-
Patent number: 12162868Abstract: The present invention relates to novel piperazine derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially for targeted therapy treatment of hyperproliferative disorders, including benign hyperproliferative disorders, cancer and pre-cancer conditions.Type: GrantFiled: August 8, 2021Date of Patent: December 10, 2024Assignee: Vidac Pharma Ltd..Inventors: Paul Salama, Vered Behar, Oren Menahem Becker
-
Patent number: 12083111Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.Type: GrantFiled: August 17, 2021Date of Patent: September 10, 2024Assignee: Vidac Pharma Ltd ..Inventors: Vered Behar, Oren Menahem Becker, Reut Yosef Hamo, Eyal Dor-On
-
Patent number: 11905250Abstract: This invention relates to methods for preparation of jasmonate compounds via a salt of jasmonic acid.Type: GrantFiled: January 6, 2019Date of Patent: February 20, 2024Assignee: VIDAC PHARMA LTD.Inventors: Paul Salama, Oren Menahem Becker
-
Publication number: 20220143004Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for treating, inhibiting, or suppressing a hexokinase-2 (HK2)-expressing cancer.Type: ApplicationFiled: January 25, 2022Publication date: May 12, 2022Applicant: Vidac Pharma Ltd.Inventors: Vered BEHAR, Oren Menahem BECKER, Hadas Tamar PAHIMA, Reut YOSEF HAMO
-
Publication number: 20220098179Abstract: The present invention relates to novel piperazine derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially for targeted therapy treatment of hyperproliferative disorders, including benign hyperproliferative disorders, cancer and pre-cancer conditions.Type: ApplicationFiled: August 8, 2021Publication date: March 31, 2022Applicant: Vidac Pharma Ltd.Inventors: Paul Salama, Vered Behar, Oren Menahem Becker
-
Patent number: 11266639Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for treating, inhibiting, or suppressing a hexokinase-2 (HK2)-expressing cancer.Type: GrantFiled: November 7, 2017Date of Patent: March 8, 2022Assignee: VIDAC PHARMA LTD.Inventors: Vered Behar, Oren Menahem Becker, Hadas Tamar Pahima, Reut Yosef Hamo
-
Publication number: 20210369697Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.Type: ApplicationFiled: August 17, 2021Publication date: December 2, 2021Applicant: Vidac Pharma Ltd.Inventors: Vered BEHAR, Oren Menahem BECKER, Reut YOSEF HAMO, Eyal DOR-ON
-
Patent number: 11096935Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.Type: GrantFiled: January 29, 2020Date of Patent: August 24, 2021Assignee: VIDAC PHARMA LTDInventors: Vered Behar, Oren Menahem Becker, Reut Yosef Hamo, Eyal Dor-On
-
Patent number: 11084807Abstract: The present invention relates to novel piperazine derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially for targeted therapy treatment of hyperproliferative disorders, including benign hyperproliferative disorders, cancer and pre-cancer conditions.Type: GrantFiled: August 17, 2017Date of Patent: August 10, 2021Assignee: VIDAC PHARAMA LTD.Inventors: Paul Salama, Vered Behar, Oren Menahem Becker
-
Publication number: 20210078949Abstract: This invention relates to methods for preparation of jasmonate compounds via a salt of jasmonic acid.Type: ApplicationFiled: January 6, 2019Publication date: March 18, 2021Applicant: Vidac Pharma Ltd.Inventors: Paul SALAMA, Oren Menahem Becker
-
Publication number: 20200297620Abstract: The present invention relates to novel pharmaceutical compositions for topical administration of a compound Formula I and methods of treating or preventing cancer or pre-cancerous conditions or benign hyperproliferative disorders, by administering the composition to a subject in need thereof. In particular, the present invention provides a stable formulation of active a compound of Formula I useful for the treatment of disorders such as actinic keratosis.Type: ApplicationFiled: March 28, 2017Publication date: September 24, 2020Applicant: Vidac Pharma LtdInventors: Paul SALAMA, Oren Menahem BECKER, Chaim MANN BRICKMAN
-
Publication number: 20200188381Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.Type: ApplicationFiled: January 29, 2020Publication date: June 18, 2020Applicant: Vidac Pharma Ltd.Inventors: Vered BEHAR, Oren Menahem BECKER, Reut YOSEF HAMO, Eyal DOR-ON
-
Patent number: 10682346Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.Type: GrantFiled: November 7, 2017Date of Patent: June 16, 2020Assignee: VIDAC PHARMA LTD.Inventors: Vered Behar, Oren Menahem Becker, Reut Yosef Hamo, Eyal Dor-On
-
Publication number: 20180303820Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for treating, inhibiting, or suppressing a hexokinase-2 (HK2)-expressing cancer.Type: ApplicationFiled: November 7, 2017Publication date: October 25, 2018Applicant: Vidac Pharma Ltd.Inventors: Vered BEHAR, Oren Menahem BECKER, Hadas Tamar PAHIMA, Reut YOSEF HAMO
-
Publication number: 20180303819Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.Type: ApplicationFiled: November 7, 2017Publication date: October 25, 2018Applicant: Vidac Pharma Ltd.Inventors: Vered BEHAR, Oren Menahem BECKER, Reut YOSEF HAMO, Eyal DOR-ON
-
Patent number: 4260656Abstract: A paper stock adapted to be employed in transport systems utilizing projecting pin-type sprocket drives includes at least one row of a plurality of spaced-apart and aligned pin-engageable drive apertures extending the length thereof, each of which drive apertures is formed by a partially open circular die-cut line having a gap between its ends of approximately 0.010 inches to 0.040 inches, the gap being oriented at the leading edge of the resulting aperture, thereby forming a strengthening hinge-like connection between the paper stock and the aperture blank when such blank is subsequently displaced, such as by engagement with a projecting pin on a drive sprocket mechanism of a transport system used to move paper stock through a machine.Type: GrantFiled: September 11, 1978Date of Patent: April 7, 1981Assignee: VIDACInventor: James W. Mullen
-
Patent number: 4041863Abstract: A precision hand-held label imprinter and dispenser includes a compact case or frame with a projecting handle and an applicator roller located remote therefrom, together with a dialable imprinter and platen assembly arranged so that a trigger lever associated with the handle may be manually acutated in one direction to imprint label stock (tape) by driving the platen across an imprinter in an engaged condition to force the printing medium and label stock thereagainst and operates in the opposite direction to separate the imprinter and platen and to simultaneously advance the printing medium and to advance the printed label stock to the applicator roller. Through a series of connected drive elements with the trigger lever, the device times the several functions so that accurate reproductions with high resolution of the dialed imprint information on each label is assured.Type: GrantFiled: July 18, 1975Date of Patent: August 16, 1977Assignee: Vidac CorporationInventors: James W. Mullen, Boone K. McReynolds, Herbert D. Pace